Biblio

Export 330 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., “Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
B. C. M. Stephan, Birdi, R., Tang, E. Yee Hing, Cosco, T. D., Donini, L. M., Licher, S., M Ikram, A., Siervo, M., and Robinson, L., “Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
Y. E. Cruz-Rivera, Perez-Morales, J., Santiago, Y. M., Gonzalez, V. M., Morales, L., Cabrera-Rios, M., and Isaza, C. E., “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., “Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., “Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.
J. Steffen, Stenzel, J., Ibrahim, S., and Pahnke, J., “Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 2, pp. 465-474, 2018.
M. Igase, Ohara, M., Igase, K., Kato, T., Okada, Y., Ochi, M., Tabara, Y., Kohara, K., and Ohyagi, Y., “Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1481-1487, 2017.
M. Igase, Ohara, M., Igase, K., Kato, T., Okada, Y., Ochi, M., Tabara, Y., Kohara, K., and Ohyagi, Y., “Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1481-1487, 2017.
C. Liguori, Spanetta, M., Izzi, F., Franchini, F., Nuccetelli, M., Sancesario, G. Maria, Di Santo, S., Bernardini, S., Mercuri, N. Biagio, and Placidi, F., “Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.”, J Alzheimers Dis, vol. 74, no. 2, pp. 501-508, 2020.
R. Wingbermühle, Wen, K. - X., Wolters, F. J., M Ikram, A., and Bos, D., “Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1191-1195, 2017.
M. Lozupone, Panza, F., Piccininni, M., Copetti, M., Sardone, R., Imbimbo, B. P., Stella, E., D'Urso, F., Barulli, M. Rosaria, Battista, P., Grasso, A., Tortelli, R., Capozzo, R., Coppola, F., Abbrescia, D. Isabel, Bellomo, A., Giannelli, G., Quaranta, N., Seripa, D., and Logroscino, G., “Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 989-1000, 2018.
J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
M. Bertoux, Flanagan, E. C., Hobbs, M., Ruiz-Tagle, A., Delgado, C., Miranda, M., Ibáñez, A., Slachevsky, A., and Hornberger, M., “Structural Anatomical Investigation of Long-Term Memory Deficit in Behavioral Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1887-1900, 2018.
T. S. Lysen, Wolters, F. J., Luik, A. I., M Ikram, K., Tiemeier, H., and M Ikram, A., “Subjective Sleep Quality is not Associated with Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 239-247, 2018.
T. S. Lysen, Wolters, F. J., Luik, A. I., M Ikram, K., Tiemeier, H., and M Ikram, A., “Subjective Sleep Quality is not Associated with Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 239-247, 2018.
N. Baazaoui, Flory, M., and Iqbal, K., “Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1385-1401, 2017.
M. Miyamoto, Kuzuya, A., Noda, Y., Ueda, S., Asada-Utsugi, M., Ito, S., Fukusumi, Y., Kawachi, H., Takahashi, R., and Kinoshita, A., “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
T
E. L. Boespflug, Simon, M. J., Leonard, E., Grafe, M., Woltjer, R., Silbert, L. C., Kaye, J. A., and Iliff, J. J., “Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
K. Yoshida, Hata, Y., Ichimata, S., and Nishida, N., “Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk.”, J Alzheimers Dis, vol. 72, no. 2, pp. 641-652, 2019.
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., “Tau in Alzheimer disease and related tauopathies.”, Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
E. E. Brown, Iwata, Y., Chung, J. Ku, Gerretsen, P., and Graff-Guerrero, A., “Tau in Late-Life Depression: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 54, no. 2, pp. 615-33, 2016.

Pages